Skip to content

Clinical randomized controlled study of Bifidobacterium brevis assisting glucocorticoid to improve asthma in children

Clinical randomized controlled study of Bifidobacterium brevis assisting glucocorticoid to improve asthma in children

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098679
Enrollment
Unknown
Registered
2025-03-12
Start date
2024-01-11
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant asthma

Interventions

Control:None
Infant asthma:None
Glucocorticoids+Beta-2 agonists +Bifidobacterium breve group:Conventional treatment with glucocorticoids + ß-2 receptor agonists was received, along with oral probiotics.
Glucocorticoids+Beta-2 agonists +Placebo:Conventional treatment with glucocorticoids plus beta-2 receptor agonists was given along with oral placebo.

Sponsors

Jingdezhen Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 3 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for childhood bronchial asthma described above. 2.Age 0-3 years old, male and female. 3.During treatment, glucocorticoid +ß2 receptor agonist + probiotics can be actively combined according to the course of treatment. 4.Patients and their families give informed consent and sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients who did not meet the inclusion criteria. 2.Patients with serious organ diseases. 3.There are immune system defects. 4.Patients allergic to the drugs used in this study. 5.Patients who resisted relevant research work and had poor compliance.

Design outcomes

Primary

MeasureTime frame
Gut microbiota composition;

Secondary

MeasureTime frame
Routine blood markers;Immunoglobulins (immunoglobulins a, immunoglobulins ?, immunoglobulins µ);Cytokine;Lung function;

Countries

China

Contacts

Public ContactHongying Yu

Jingdezhen Second People's Hospital

yyb89009@qq.com+86 139 7986 2619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026